raloxifene hydrochloride has been researched along with 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, H; Wang, S; Wu, B; Zhou, X | 1 |
1 other study(ies) available for raloxifene hydrochloride and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester
| Article | Year |
|---|---|
Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites.
Topics: Arylsulfotransferase; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Diketopiperazines; Enzyme Induction; HEK293 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Metabolic Detoxication, Phase II; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Propionates; Quinolines; Raloxifene Hydrochloride; RNA Interference; Selective Estrogen Receptor Modulators; Sulfates; Transfection | 2015 |